RESEARCH DASHBOARD
-
RELEASE DATE
OCT 2025 -
Executive Pool
7051 -
PRICE
US$5850 -
EXPERT INPUTS
811 -
Companies
36 -
DATA Tables
150 -
Pages
216 -
Edition
2
WHAT'S BEHIND OUR DATA?
-
DOMAIN TRANSCRIPTS
140857226 -
BRANDS TRACKED
6080276 -
FEATURED COMPANIES
1729341 -
TOPICS COVERED
22574 -
MARKET SEGMENTS
82719 -
KEY INDUSTRIES
91 -
CURATION TEAM
1574 -
DECISION MAKERS
4761909
EXECUTIVES TRACKED (55)
-
CXO
3 -
VICE PRESIDENT
5 -
DIRECTOR
10 -
MANAGER
25MARKETING
12
EXECUTIVE INSIGHTS
DOMAIN EXPERTS
PLAYERS
PARTICIPANTS
-
OCT 2025
-
EDITION 2
-
TABLES 150
-
REGIONS 12
-
SEGMENTS 8
-
PAGES 216
-
US$ 5850
-
MCP29298
-
JOIN OUR PANEL
SELECT LICENSE TYPE
HIGHLIGHTS & REPORT INDEX
Global Atopic Dermatitis Clinical Trials Market to Reach US$5.0 Billion by 2030
The global market for Atopic Dermatitis Clinical Trials estimated at US$2.8 Billion in the year 2024, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2024-2030. Small Molecules, one of the segments analyzed in the report, is expected to record a 12.3% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Large Molecules segment is estimated at 8.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$727.5 Million While China is Forecast to Grow at 9.4% CAGR
The Atopic Dermatitis Clinical Trials market in the U.S. is estimated at US$727.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$769.8 Million by the year 2030 trailing a CAGR of 9.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.5% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.
Global Atopic Dermatitis Clinical Trials Market - Key Trends & Drivers Summarized
How Are Clinical Trials Advancing Atopic Dermatitis Treatments?
Atopic dermatitis, a chronic inflammatory skin condition, has prompted significant advancements in clinical trials aimed at identifying effective treatments. These trials focus on novel therapies, including biologics, JAK inhibitors, and non-steroidal topical formulations, to address unmet medical needs. Personalized medicine approaches are gaining prominence, with researchers exploring genetic and environmental factors influencing the condition. The integration of real-world evidence and digital health tools, such as wearable devices and telemedicine, is enhancing trial efficiency and patient engagement. These innovations are accelerating the development of targeted therapies for atopic dermatitis.
What Trends Are Driving Atopic Dermatitis Clinical Trials?
Several trends are shaping the atopic dermatitis clinical trials landscape. The rising prevalence of the condition, particularly in pediatric populations, has spurred research initiatives. Pharmaceutical companies are investing heavily in biologics and small-molecule drugs to capture market share in this competitive space. Patient-centric trial designs, emphasizing convenience and remote monitoring, are improving recruitment and retention rates. Additionally, regulatory incentives, such as fast-track designations for innovative treatments, are expediting trial timelines. These trends reflect the urgency to develop effective and accessible therapies for atopic dermatitis.
Why Are Biologics Dominating Atopic Dermatitis Research?
Biologics have emerged as a focal point in atopic dermatitis research due to their ability to target specific immune pathways implicated in the condition. Monoclonal antibodies, such as dupilumab, have demonstrated significant efficacy in reducing symptoms and improving quality of life for patients. The success of existing biologics has encouraged further exploration of new targets, such as IL-13 and IL-31, driving innovation in the field. These therapies offer hope for long-term disease management, especially for patients with moderate to severe forms of atopic dermatitis, reinforcing their prominence in clinical trials.
What Drives the Growth in the Atopic Dermatitis Clinical Trials Market?
The growth in the atopic dermatitis clinical trials market is driven by rising disease prevalence, advancements in biologics, and increasing adoption of patient-centric approaches. The demand for targeted therapies has encouraged pharmaceutical companies to invest in innovative treatment pipelines. Regulatory support, including orphan drug designations and expedited approvals, has incentivized clinical trial activities. Additionally, the integration of digital health technologies is streamlining trial operations and improving patient outcomes. These factors collectively underscore the significant growth potential of the atopic dermatitis clinical trials market.
SCOPE OF STUDY
The report analyzes the Atopic Dermatitis Clinical Trials market by the following Segments, and Geographic Regions/Countries:
Segments:
Molecule Type (Small Molecules, Large Molecules); Study Design (Interventional Trials, Observational Trials); Phase (Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial, Phase IV Clinical Trial).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Amgen Inc.; Biocytogen; Charles River Laboratories International, Inc.; Eli Lilly and Company; Hooke Laboratories, LLC; Imavita S.A.S.; Novartis International AG; Novotech; Oncodesign Services; Pfizer, Inc.; QIMA Life Sciences; Redoxis; Regeneron Pharmaceuticals, Inc.; ReproCELL, Inc.; Syneos Health;
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Atopic Dermatitis Clinical Trials – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 36 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Surge in Biologic Therapies Spurs Advanced Clinical Trials |
| Growing Focus on Personalized Medicine Enhances Trial Design Complexity |
| Increasing Prevalence of Atopic Dermatitis Boosts Research Investments |
| Advancements in Genetic and Biomarker Research Drive Trial Innovation |
| Rising Pediatric Cases Lead to Specialized Trial Segments |
| Demand for Faster FDA Approvals Accelerates Adaptive Trial Designs |
| Patient-Centric Approaches Improve Trial Recruitment and Retention |
| Use of Digital Health Tools Enhances Remote Monitoring in Trials |
| Real-World Evidence Integration Expands Post-Trial Market Insights |
| Emergence of Novel Topical Therapies Broadens Clinical Pipelines |
| Artificial Intelligence Streamlines Trial Matching and Site Selection |
| Global Expansion of Trials Increases Access to Diverse Patient Populations |
| Strategic Partnerships Between Pharma and CROs Improve Trial Execution |
| Government and NGO Funding Accelerates Early-Stage Research |
| Emphasis on Long-Term Safety Data Drives Extended Trial Durations |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Atopic Dermatitis Clinical Trials Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Atopic Dermatitis Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Atopic Dermatitis Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Small Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Small Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Large Molecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Large Molecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Interventional Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Interventional Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Interventional Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Observational Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Observational Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Observational Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Phase I Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Phase I Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Phase I Clinical Trial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Phase II Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Phase II Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Phase II Clinical Trial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Phase III Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Phase III Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Phase III Clinical Trial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Phase IV Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Phase IV Clinical Trial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Phase IV Clinical Trial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| JAPAN |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| CHINA |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| EUROPE |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Atopic Dermatitis Clinical Trials by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| FRANCE |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| GERMANY |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Atopic Dermatitis Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Atopic Dermatitis Clinical Trials by Molecule Type - Small Molecules and Large Molecules Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Atopic Dermatitis Clinical Trials by Molecule Type - Percentage Breakdown of Value Sales for Small Molecules and Large Molecules for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Atopic Dermatitis Clinical Trials by Study Design - Interventional Trials and Observational Trials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Atopic Dermatitis Clinical Trials by Study Design - Percentage Breakdown of Value Sales for Interventional Trials and Observational Trials for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Atopic Dermatitis Clinical Trials by Phase - Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Atopic Dermatitis Clinical Trials by Phase - Percentage Breakdown of Value Sales for Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial and Phase IV Clinical Trial for the Years 2015, 2025 & 2030 |